Skip to content
Wenlo
Sign in
← Markets

IDEXX Laboratories, Inc.

Michael Lane (Executive Vice President) reports IDXX insider transactions

4IDXXFiled Nov 20, 2026, 5:00 PM ET· Period Nov 18, 2026

AI-generated summary

Executive Vice President Michael Lane acquired 863 shares of Common Stock valued at $299,108.07 by exercising or converting derivatives on November 18, 2026. Following these transactions, the insider directly held 4,939 shares of Common Stock.

Key facts

Insider
Michael Lane · Executive Vice President
DateTransactionSharesPriceValueHeld afterOwnership
Nov 18, 2026M · exercise or conversion of a derivative+483$206.94$99,952.024,559Direct
Nov 18, 2026M · exercise or conversion of a derivative+183$544.08$99,566.644,742Direct
Nov 18, 2026M · exercise or conversion of a derivative+197$505.53$99,589.414,939Direct
Nov 18, 2026M · exercise or conversion of a derivativeIncentive Stock Option (right-to-buy)Footnotes F2−483$0.00$0.000Direct
Nov 18, 2026M · exercise or conversion of a derivativeIncentive Stock Option (right-to-buy)Footnotes F3−183$0.00$0.000Direct
Nov 18, 2026M · exercise or conversion of a derivativeIncentive Stock Option (right-to-buy)Footnotes F4−197$0.00$0.000Direct
Footnotes
  1. F1 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
  2. F2 Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024
  3. F3 Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2025.
  4. F4 Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2026.

More IDXX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.